Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

NCT07226713 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Medical College of Wisconsin